Pediatrix Q4 EPS $0.40; Adj. EPS $0.50; guides 2026 EBITDA $280-300M

Pediatrix Medical Group, Inc.

2025-FY EPS reported $1.94 revenue$1,913,849,000

Net revenue $494M, down slightly YoY; same-unit revenue up 4.0%.
Q4 GAAP net income $33.7M ($0.40/share) vs $30.5M ($0.36) prior year; Adjusted EPS $0.50.
Full year 2025 Adjusted EBITDA $275.6M, up from $224M; Adjusted EPS $2.04 vs $1.51.
Preliminary 2026 Adjusted EBITDA guidance $280-300M, above 2025's $275.6M.
Cash from operations $114.6M in Q4; used $64M for share repurchases; total debt $597M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.